colestipol has been researched along with Hyperlipemia in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (78.33) | 18.7374 |
1990's | 11 (18.33) | 18.2507 |
2000's | 2 (3.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azen, SP; Blankenhorn, DH; Nessim, SA | 1 |
Nash, DT | 1 |
Kuo, PT | 1 |
Faruqui, AM; Thurmond, MS; Wenger, J; Wenger, NK | 1 |
Boberg, J; Hellsing, K; Lithell, H; Vessby, B | 1 |
Havel, RJ; Kane, JP | 1 |
Saudek, CD | 1 |
Desager, JP; Harvengt, C | 2 |
Albers, JJ; Cheung, MC; Hazzard, WR; Wahl, PW | 1 |
Samuel, P | 1 |
Barth, JD; Mancini, GB | 1 |
Chin, MM; Jozefiak, E; Morales, E; Spinler, SA; Wilson, MD | 1 |
Kłosiewicz-Latoszek, L; Nowicka, G; Szostak, WB | 1 |
Barbir, M; Galloway, D; Hunt, BJ; Ilsley, C; Mitchell, A; Taylor, A; Yacoub, M | 1 |
Florkowski, CM; Scott, RS | 1 |
Ose, L; Tonstad, S | 1 |
Bambauer, R; Müller, UA; Schiel, R | 1 |
Farmer, JA; Gotto, AM | 1 |
Albers, JJ; Bardsley, J; Brown, BG; Dowdy, A; Hillger, LA; Knopp, RH; Maher, VM; Poulin, D; Zhao, XQ | 1 |
Brown, BG; Brunzell, JD; Deeb, SS; Hokanson, JE; Zambon, A | 1 |
Conner, WT; Cullen-Dean, G; Helden, E; McCrindle, BW | 1 |
Heimann, KW; Stein, EA | 1 |
Fallat, RW; Glueck, CJ; Mellies, M; Tsang, RC | 1 |
Hayase, K; Kostis, JB; Kuo, PT; Moreyra, AE | 1 |
Dillingham, MA; Giese, WE; Schonfeld, G; Weidman, SW; Witztum, JL | 1 |
Vogelberg, KH | 1 |
Levy, RI | 2 |
Mertz, DP | 1 |
Fleischmajer, R | 1 |
Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R | 1 |
Heuck, CC; Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G; Twelsick, F | 1 |
Debry, G; Drouin, P; Lambert, D; Mejean, L; Sauvanet, JP | 1 |
Blankenhorn, DH; Sanmarco, ME | 1 |
Grundy, SM; Mok, HY | 1 |
Hanefeld, M | 1 |
Cooper, EE; Michel, AM | 1 |
Fallat, RW; Glueck, CJ; Mellies, MJ; Tsang, RC | 1 |
Fumagalli, R; Sirtori, CR; Torreggiani, D | 1 |
Miller, NE; Nestel, PJ | 1 |
Baggio, G; Baiocchi, MR; Balestrieri, P; Briani, G; Crepaldi, G; Fellin, R | 1 |
Kudchodkar, B; Nestel, PJ | 1 |
Gotto, AM; Yeshurun, D | 1 |
D'Amico, G; Gentile, MG | 1 |
Cutler, RE; Feng, Y; Forland, SC | 1 |
LaRosa, J | 1 |
Brown, WV | 1 |
Dereviacki, BE; Forti, N; Giannini, SD | 1 |
Demke, DM; Grzegorczyk, CR; Linet, OI | 1 |
Kane, JP; Malloy, MJ | 1 |
Naito, HK | 1 |
Davignon, J | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Packard, CJ; Shepherd, J | 1 |
Crouse, JR | 1 |
Parker, F | 1 |
15 review(s) available for colestipol and Hyperlipemia
Article | Year |
---|---|
Therapy of hyperlipidemic states.
Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Combination; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins, LDL; Lipoproteins, VLDL; Niacin; Nicotinic Acids; Sitosterols | 1982 |
An update on lipid-lowering therapy.
Topics: Aged; Anticholesteremic Agents; Colestipol; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Patient Compliance | 1995 |
Noninsulin dependent diabetes mellitus: the importance of dyslipidaemia.
Topics: Cholestyramine Resin; Colestipol; Contraindications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents | 1994 |
Choosing the right lipid-regulating agent. A guide to selection.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides | 1996 |
[Lipid-lowering drugs. Therapeutics and adverse effects].
Topics: Arteriosclerosis; Child; Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Phenoxyacetates; Sitosterols | 1979 |
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Mechanism of action of hypolipidemic drugs.
Topics: Acetoacetates; Animals; Brain; Cholesterol; Clofibrate; Colestipol; Ethanol; Humans; Hydroxybutyrates; Hydroxyindoleacetic Acid; Hyperlipidemias; Liver; Nerve Tissue Proteins; Polyamines; Rats; Triglycerides; Tryptophan | 1975 |
Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Gastrointestinal Diseases; Humans; Hyperlipidemias; Polyamines | 1989 |
Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs.
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Fenofibrate; Humans; Hyperlipidemias; Lovastatin; Nicotinic Acids; Propionates; Simvastatin | 1989 |
Bile acid sequestrants and hyperlipidaemia.
Topics: Cholestyramine Resin; Colestipol; Humans; Hyperlipidemias; Lipoproteins, LDL; Polyamines | 1988 |
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol | 1988 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol | 1987 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Pharmacological modification of lipoprotein metabolism.
Topics: Animals; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Niacin; Sterols | 1987 |
17 trial(s) available for colestipol and Hyperlipemia
Article | Year |
---|---|
Treatment of hyperlipidaemia and progression of atherosclerosis.
Topics: Adult; Arteriosclerosis; Colestipol; Double-Blind Method; Female; Humans; Hyperlipidemias; Middle Aged; Niacin | 1983 |
The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Topics: Alkaline Phosphatase; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hyperlipoproteinemias; Insulin; Male; Middle Aged; Polyamines; Time Factors; Triglycerides; Uric Acid | 1980 |
High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.
Topics: Adult; Aged; Aminosalicylic Acid; Apolipoproteins; Cholesterol; Clofibrate; Colestipol; Drug Evaluation; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Oxandrolone; Statistics as Topic | 1980 |
A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting.
Topics: Analysis of Variance; Bezafibrate; Colestipol; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Factor VII; Factor VIII; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pilot Projects; Simvastatin | 1994 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life | 1995 |
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease.
Topics: Cholesterol, LDL; Colestipol; Cross-Over Studies; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance | 1997 |
Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
Topics: Analysis of Variance; Cholesterol, HDL; Colestipol; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Genotype; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Lovastatin; Male; Middle Aged; Niacin; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Promoter Regions, Genetic; Regression Analysis | 2001 |
A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia.
Topics: Adolescent; Child; Colestipol; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Patient Compliance; Patient Selection; Pravastatin; Treatment Outcome | 2002 |
Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Placebos; Polyamines; Triglycerides | 1975 |
Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Topics: Adolescent; Adult; Child; Cholesterol; Clinical Trials as Topic; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Placebos; Polyamines; Triglycerides; Xanthomatosis | 1976 |
Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis; Cholesterol; Colestipol; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Drug Evaluation; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Placebos; Polyamines; Radiography; Triglycerides; Xanthomatosis | 1979 |
[Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
Topics: Adult; Aged; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Polyamines; Propionates | 1978 |
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
Topics: Cholestyramine Resin; Colestipol; Food, Formulated; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Lovastatin; Nephrotic Syndrome; Probucol | 1991 |
Apparent reduced absorption of gemfibrozil when given with colestipol.
Topics: Aged; Biological Availability; Cholesterol; Colestipol; Drug Interactions; Gemfibrozil; Humans; Hyperlipidemias; Intestinal Absorption; Middle Aged; Polyamines; Triglycerides | 1990 |
Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Gastrointestinal Diseases; Humans; Hyperlipidemias; Polyamines | 1989 |
Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs.
Topics: Anticholesteremic Agents; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Fenofibrate; Humans; Hyperlipidemias; Lovastatin; Nicotinic Acids; Propionates; Simvastatin | 1989 |
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol | 1988 |
31 other study(ies) available for colestipol and Hyperlipemia
Article | Year |
---|---|
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases.
Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates | 1983 |
Treating hyperlipidemia to provide salutary effect on coronary artery disease.
Topics: Arteriosclerosis; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Lipoproteins, LDL | 1984 |
Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
Topics: Adult; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Male; Polyamines | 1981 |
Hyperlipidemia - a diabetic emergency.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Colestipol; Diabetes Complications; Diagnosis, Differential; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Middle Aged; Nicotinic Acids; Triglycerides | 1982 |
[Pharmacokinetics of fenofibrate in man (author's transl)].
Topics: Colestipol; Drug Interactions; Fenofibrate; Half-Life; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases; Kinetics; Propionates | 1980 |
Management of the hyperlipidaemias.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Female; Humans; Hyperlipidemias; Nicotinic Acids | 1980 |
Drug treatment of hyperlipidemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol | 1980 |
Criteria for use of hypolipidemic agents in adults.
Topics: Adult; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Niacin; Risk Factors | 1994 |
[Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
Topics: Adult; Aged; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged | 1993 |
The detection and management of dyslipidaemia in children and adolescents.
Topics: Adolescent; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Diet Therapy; Female; Humans; Hyperlipidemias; Male | 1995 |
Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Topics: Adolescent; Adult; Child; Cholesterol; Colestipol; Female; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Polyamines; Triglycerides | 1976 |
Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins.
Topics: Adult; Apolipoproteins; Bile; Body Weight; Colestipol; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Polyamines | 1979 |
[Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Germany, West; Humans; Hyperlipidemias; Hypolipidemic Agents; Legislation, Drug; Nicotinic Acids; Sitosterols; Thyroxine | 1979 |
Hypolipidemic drugs.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol | 1978 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols | 1978 |
[A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Phospholipids; Polyamines | 1978 |
Angiography for study of lipid-lowering therapy.
Topics: Colestipol; Coronary Angiography; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias; Patient Dropouts; Polyamines; Risk; Technology, Radiologic | 1979 |
Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Middle Aged; Phytosterols; Polyamines; Steroids; Triglycerides | 1977 |
[Drug treatment of hyperlipoproteinemias].
Topics: Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Erectile Dysfunction; Female; Humans; Hyperlipidemias; Male; Nicotinic Acids | 1977 |
Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary.
Topics: Bile Acids and Salts; Cholestasis; Cholesterol; Colestipol; Humans; Hyperlipidemias; Polyamines | 1977 |
Treatment of hyperlipidemias in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Triglycerides | 1977 |
Drug therapy of hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Drug Therapy, Combination; Humans; Hyperlipidemias; Nicotinic Acids; Sitosterols | 1976 |
Differences among hyperlipoproteinaemic subjects in the response of lipoprotein lipids to resin therapy.
Topics: Adult; Cholesterol; Colestipol; Female; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Polyamines | 1975 |
[Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Topics: Adult; Angina Pectoris; Cholesterol; Colestipol; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Polyamines; Triglycerides; Xanthomatosis | 1975 |
Plasma squalene as an index of cholesterol synthesis.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Squalene | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
The effect of encapsulated, low-dose colestipol in patients with hyperlipidemia.
Topics: Capsules; Cholesterol; Colestipol; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Polyamines | 1988 |
Medical management of hyperlipidemia and the role of probucol.
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Polyamines; Time Factors; Triglycerides | 1987 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |